Introduction
Chronic severe pulmonary valve regurgitation (PVR) following the surgical repair of tetralogy of Fallot (TOF) and similar pathologies in infancy leads to right ventricular enlargement, which predisposes patients to right heart failure, arrhythmias, and sudden cardiac death. Subsequently, nearly all of these patients require pulmonary valve implantation (PVI) later in life (1) . PVI can be performed either through a surgery (under cardiopulmonary bypass) or transcatheter route. In cases where the patient's condition poses high risk for surgery and/or is not suitable for transcatheter PVI, a hybrid procedure might be an alternative approach.
Case Report
Between November 2014 and January 2018, 52 patients were evaluated for percutaneous PVI. Of these patients, 45 received percutaneous PVI and four were not suitable for percutaneous PVI and therefore underwent surgical PVI. The remaining three patients underwent a hybrid PVI procedure. Here, we present these three patients who had severe PVR after the transannular patch repair of TOF in the infancy.
Procedure: Basic tests for PVI (coronary compression and balloon interrogation tests) were performed during previous cardiac catheterization; therefore, patients directly underwent stenting and valve implantation during the hybrid procedure. Table 1 shows the indications and demographic data of cases.
All patients were intubated under general anesthesia. A left anterior 8-10-cm thoracotomy was performed to expose the right ventricular (RV) anterior wall (Fig. 1a) . Two purse string stitches with pledgets were placed on the RV anterior wall. An 18-gauge needle was used to puncture the RV wall, and an 11-Fr introducer sheath was placed in RV.
Initially, the Back-up Meier guidewire was placed in the distal pulmonary artery; then, an 11-Fr sheath was exchanged with a 26-Fr Edwards SAPIEN delivery sheath (Edwards Life Sciences, Irvine, CA) over the wire (Fig. 1b) . Second, a 48-mm Andra XXL stent (Andramed, Reutlinger, Germany) was mounted over a 30 mm×4.5-cm Z-med balloon (NuMED, Inc., Hopkinton, NY, USA) and deployed in to the right ventricular outflow tract/main pulmonary artery over the wire. Next, either an Edwards SAPIEN XT or S3 valve (Edwards Life Sciences, Irvine, CA) was deployed under fluoroscopic guidance. Control angiography of the main pulmonary artery showed a well-placed, well-functioning pulmonary valve without significant pulmonary insufficiency (Video 1). The sheath was removed, and the purse string sutures were tightened (Fig. 1c) . A 24-Fr drain was placed, and the chest was closed. All patients were extubated in the catheterization laboratory. The patients received aspirin for the next 6 months ( Table 1) .
Discussion
In the literature, several hybrid PVI techniques have been described (1) (2) (3) (4) (5) ; however, all these hybrid PVI procedures involved some sort of surgical exposure, from a limited subxyphoid incision to anterior thoracotomy or full median sternotomy (5) . Each method has different advantages and indications. Table 1 summarizes our indications for the hybrid approach.
The implementation of hybrid approach makes PVI possible without crossing the tricuspid valve with large and stiff delivery systems. Also, it improves patient safety by reducing the procedure time (3). Other benefits of hybrid PVI are as follows: lower possibility of blood transfusion; avoidance of warm beatingheart cardiopulmonary bypass, and the psychological promise of avoiding open-heart surgery (5). The hybrid approach reduces the impact of patient size on the procedure as it is not limited by the small size of a child's vascular system (3). We suggested that a straightforward catheter course during the hybrid approach facilitates advancing the pulmonary valve system into MPA. Also, an operator can easily change the course of the valve during the whole procedure by manipulating the angle of the apical delivery system. 
